Cerecin Announces Publication of Clinical Study Demonstrating Promising Results of CER-0001 (tricaprilin) for Rare Pediatric Epilepsy

The Potential of Fasting and Diet in the Future of Medicine

Cerecin Joins NIHR HealthTech Research Centre in Brain Health as an Industry Partner

Cerecin Signs an MOU with Cha Bundang Hospital

Cerecin Expands Leadership Team with Appointment of Chief Medical Officer and Chief Operating Officer

Cerecin Bolsters Pipeline with a Strategic Acquisition From Boston Scientific

Cerecin forges strategic partnership with A*STAR's Institute of Molecular and Cell Biology (IMCB) in Singapore to advance R&D in neurological disorders

Cerecin strengthens position in neurometabolism with addition to pipeline

Cerecin to Present New Infantile Spasms Data at the 35th Interna1onal Epilepsy Congress, Dublin 2023

Clinical Trial Data of Novel Metabolic Mechanism in Migraine: CER-0001, a Ketogenic Investigational Agent